Log In
BCIQ
Print this Print this
 

PsoriasisDX

  Manage Alerts
Collapse Summary General Information
Company DermaGenoma Inc.
DescriptionTest to identify individuals at high risk for developing psoriatic arthritis
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationAutoimmune, Diagnostic
Indication DetailsIdentify patients at risk for psoriatic arthritis
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today